A5030938991- Cardiac Structural Anomalies and Repair
- Mechanical Circulatory Support Devices
- Cardiac Valve Diseases and Treatments
- Transplantation: Methods and Outcomes
- Cardiac Health and Mental Health
- Heart Failure Treatment and Management
- Cardiac Arrest and Resuscitation
- Heart Rate Variability and Autonomic Control
- Hormonal Regulation and Hypertension
- Acute Myocardial Infarction Research
- Blood Coagulation and Thrombosis Mechanisms
- Atrial Fibrillation Management and Outcomes
- Renal Transplantation Outcomes and Treatments
- Pomegranate: compositions and health benefits
- Electric and Hybrid Vehicle Technologies
- Elevator Systems and Control
- Sepsis Diagnosis and Treatment
- Takotsubo Cardiomyopathy and Associated Phenomena
- Neonatal and Maternal Infections
- Blood Pressure and Hypertension Studies
- Antimicrobial Resistance in Staphylococcus
- Autoimmune and Inflammatory Disorders Research
- Streptococcal Infections and Treatments
- Parvovirus B19 Infection Studies
- Stroke Rehabilitation and Recovery
Columbia University Irving Medical Center
2024-2025
Presbyterian Hospital
2024-2025
New York Hospital Queens
2024-2025
Columbia University
2024-2025
NewYork–Presbyterian Hospital
2024-2025
Rambam Health Care Campus
2021-2024
Emek Medical Center
2020
Bar-Ilan University
2014
Western Galilee Hospital
2014
ABSTRACT Background GLP‐1 RAs improve cardiometabolic outcomes in obese, diabetic, and heart failure patients. Data on the safety efficacy of RA advanced with durable LVAD is limited. Objectives To assess Methods We conducted a single‐center retrospective analysis patients support treated RA. Outcomes included related adverse events up to 1 year post initiation. Results Forty were therapy between 2018 2023. At follow‐up, patient's weight was significantly reduced (116 (98–134) vs. 110...
ABSTRACT Introduction Durable left ventricular assist devices (LVADs) improve outcomes for advanced heart failure (HF) patients. Vericiguat, which enhances HF by affecting systemic and pulmonary vasculature, may benefit LVAD patients as well. Methods The study aimed to investigate the safety efficacy of Vericiguat in patient on support. This retrospective analysis included supported with who were treated Vericiguat. Safety comprised LVAD‐related hemocompatibility‐related adverse events...
Background Thrombin, a key enzyme of the clotting system, is involved in thrombus formation, platelet activation, and atherosclerosis, thereby possessing central role pathogenesis ischemic heart disease. Studies have shown an association between thrombin generation (TG) cardiovascular morbidity mortality, but results been equivocal. Our aim was to study predictive ability TG assay evaluating coronary stenosis severity. Methods In this prospective we recruited patients with acute syndrome...
To evaluate the clinical implications of adjunctive molecular gene expression analysis (MMDx ) biopsy specimens in heart transplant (HT recipients with suspected rejection.
Abstract Background Cardiomyopathies account for more than half of the cardiovascular disease during peripartum period. In extreme, patients may present with cardiogenic shock (CS) requiring mechanical circulatory support (MCS). The aim this study was to report our experience CS MCS in Methods We a single‐center retrospective analysis all cases involving period that occurred between 2012 and 2023. Results Eleven were included. Median age 33, median BMI 30.4, 73% underwent caesarian‐section...
ABSTRACT Background Donor‐derived cell‐free DNA (dd‐cfDNA) has emerged as a reliable, noninvasive method for the surveillance of allograft rejection in heart transplantation (HT) patients, but its utility multi‐organ transplants (MOT) is unknown. We describe our experience using dd‐cfDNA simultaneous MOT recipients. Methods A single‐center retrospective review all HT recipients between 2018 and 2022 that had at least one measurement collected. Patients who were identified included this...
Abstract Background Congestion and volume overload are strongly associated with low quality of life pose a significant risk for both rehospitalization mortality in heart failure (HF) patients. Despite the widespread use diuretics HF, weekly, intravenous (IV), high-intensity diuretic treatment has not been prospectively studied setting ambulatory congestion-refractory Purpose To assess efficacy safety weekly diuresis regimens practical day care chronically congested HF Methods We performed...
Abstract Introduction Congestion stands as a primary driver behind exacerbating heart failure (HF), leading to hospitalizations and increased mortality rates. Despite the evident significance of congestion prognostic indicator, there exists pressing need for straightforward, trustworthy assessment method that caters various healthcare providers' needs. Aims To assess feasibility compare accuracy nurse-led using radar based dielectric sensing (ReDS) "gold-standard" point care lung ultrasound...
Introduction: Limited knowledge exists regarding the influence of sex on rejection-related gene-expression profiling using Molecular Microscope (MMDx). Methods: We prospectively included all heart transplant recipients who underwent endomyocardial biopsy for clinical indication from November 2022 to May 2024 at New York Presbyterian. During procedure, four samples were sent histologic evaluation, and two molecular analysis. Donor-derived cell-free DNA levels (dd-cfDNA%), peripheral (pGEP)...
Abstract Thrombin plays a central role in sepsis pathophysiology. The correlation of thrombin generation (TG) assays with infection severity and prognosis, whether it can be used as clinical tool, have been poorly explored are the subjects our research. We recruited 130 patients systemic between 2016 2019. Patients were divided according to by using sequential organ failure assessment (SOFA) quickSOFA (qSOFA) scores. hemostatic state was analyzed Calibrated Automated Thrombogram. primary end...